Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-24

Clinical Trial Update: EXPAREL Infiltration in Subjects Undergoing Femoral Nerve Block With Bupivacaine HCl for Total Knee Arthroplasty [Phase 4]

View source ↗

Summary

Phase 4 trial update for EXPAREL infiltration with bupivacaine in femoral nerve block during total knee arthroplasty; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine)

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Pain | Phase 4 | Status: COMPLETED | Results posted: 2020-11-24